| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b29ba1a7f2e238a79002c95123eab8a3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 |
| filingDate |
2014-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64b98ad2ab3e9bcf7e31a6212f457d53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b40cd28beb526aa7880a751ded02e5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e89c69c3444bd2a7ec1987ed24aa9bd |
| publicationDate |
2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2853257-A1 |
| titleOfInvention |
Pharmaceutical formulations of linagliptin |
| abstract |
A pharmaceutical formulation for therapeutically effective amount of linagliptin or pharmaceutically acceptable salt thereof comprising croscarmellose sodium and at least one other pharmaceutically acceptable excipient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107174571-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019203771-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019203771-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3156048-A1 |
| priorityDate |
2013-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |